Abstract
Keratinocytes are the major target of sunlight, and they produce prostaglandin (PG) E2 upon ultraviolet (UV) exposure. Although indomethacin, one of cyclooxygenase inhibitors, is known to suppress UV-induced acute skin inflammation, it remains uncertain whether endogenous PGE2 is responsible for UV-induced skin inflammation, and which subtype of PGE2 receptors mediates this process. UV-induced skin inflammation was investigated by using genetically and pharmacologically PGE2 receptor-deficient mice. We applied UV-induced skin inflammation model to genetical and pharmacological PGE2 receptor-deficient mice. We exposed UVB on these mice at 5 kJ/m2, and examined the ear swelling and the histological findings. We also measured the blood flow using a laser doppler device to assess the intensity of UVB-induced inflammatory change. The UV-induced ear swelling at 48 h after exposure was significantly reduced in EP2−/−, EP4−/− or wild-type mice treated with the EP4 antagonist compared to control mice. Consistently, inflammatory cell infiltration into the local skin, and local blood flow after UV exposure were significantly reduced by EP2 or EP4 signaling blockade. These data suggest that PGE2-EP2/EP4 signaling is mandatory in UV-induced acute skin inflammation, presumably by enhancing blood flow in the microenvironment.
Similar content being viewed by others
Main
Ultraviolet light (UV) radiation has a wide variety of actions, such as sunburn formation, immunosuppression, skin aging and cancer development. Acute skin inflammation is another effect of UV radiation and is characterized by erythema and edema. Vasodilatation at the early phase after UV exposure is a critical event, leading to skin accumulation of inflammatory cells, such as neutrophils and T cells.1 In addition, UV exposure to the skin triggers the release of lipid mediators such as prostaglandins (PGs), which are produced via sequential pathways involving cyclooxygenase (COX) and each PG synthetase. Among PGs, PGE2 is known to be produced abundantly by keratinocytes in the skin on UV exposure.2, 3
PGE2 exerts its actions by binding to four different types of G-protein-coupled receptors, known as EP1, EP2, EP3 and EP4.4 EP2 and EP4 receptors bind to Gs and increase cAMP. EP1 receptors are coupled to Gq and EP3 receptors mostly to Gi.4 We have previously generated mice individually deficient in each of the four subtypes of PGE2 receptors and studied the in vivo significance of each PGE2 receptor with novel findings in various aspects.5, 6, 7, 8, 9, 10, 11
It is well known in humans that indomethacin, one of COX inhibitors, inhibits UV-induced acute skin inflammation,12 and an exogenous intradermal injection of PGE2 increases skin microenvironmental blood flow.13 Although these observations have suggested that PGE2 serves as a mediator in the UV-induced skin alterations, it remains uncertain whether endogenous PGE2 is responsible for UV-induced skin inflammation, and which subtype of PGE2 receptors mediates this process. Using both genetical and pharmacological approaches in mice, we examined in vivo the potential role of PGE2 in UV-induced skin inflammation.
Materials and methods
Animals
Mice lacking the EP1, EP2, EP3 and EP4 receptors individually (EP1−/−, EP2−/−, EP3−/− and EP4−/− mice, respectively) were generated as described.5, 6, 7, 8 With the exception of EP4−/− mice, each mutant was backcrossed 10 times to C57BL/6CrSlc (Japan SLC, Shizuoka, Japan), and females of the F2 progenies of N10 mice were used with C57BL/6 female mice as their controls. Mice were maintained on a 12-h light/dark cycle under specific pathogen-free conditions. All experimental procedures were approved by the Committee on Animal Research of Kyoto University Faculty of Medicine.
Reagents
EP4 antagonist, ONO-AE3-208, 4-(4-Cyano-2-(2-(4-fluoronaphthalen-1-yl) propionylamino) phenyl) butyric acid (AE3-208) was kindly provided by Ono Pharmaceutical Co., Osaka, Japan. AE3-208 was administered (10 mg/kg/day) orally in the drinking water 2 days before UV exposure and through the experiment. A volume of 20 μl of 1% wt/vol indomethacin in acetone was topically applied on the ears of mice immediately after UV irradiation.
UVB Irradiation
Sunlamps emitting 280–360 nm with a peak emission at 312.5 nm (Toshiba FL 20SE; Toshiba Electric Co.) were used as a source of UVB. The irradiance was 5.5 J/m2/s at a distance of 40 cm, as measured by an UVR-305/365D digital radiometer (Tokyo Kogaku Kikai KK, Tokyo, Japan). For UV-induced skin inflammation, mice were exposed to 5 kJ/m2 of UVB. The ear swelling was measured at the indicated time points after irradiation using ear thickness gauge, and the ear thickness change was shown.14
Determination of PGE2 Content in the Mouse Skin
The amounts of PGE2 in the mouse abdominal skin at 0 and 48 h after irradiation with 5 kJ/m2 of UVB were determined by enzyme immunoassay basically as manufacturer's protocol (Cayman Chemical). In brief, abdominal skin was excised and immediately dropped into liquid nitrogen. Frozen skin were weighted and homogenized with a polytron homogenizer in 10 ml ethanol containing 0.1 ml of 5 N HCl, which was precooled at −20°C. After centrifugation, PGE2 in the ethanol extract were applied on SEP-PAK C18 cartridges (Waters Associates, Milford, MA, USA). The amounts of PGE2 were measured by enzyme immunoassay kits (Cayman Chemical, Ann Arbor, MI, USA).
Histology
The skin of the ear was excised and fixed in 10% formaldehyde. Sections of 5 μm thickness were prepared and subjected to staining with hematoxylin and eosin. The numbers of neutrophils and lymphocytes per field (× 20) were counted at five randomized spots using microscopy. The diameter of randomly selected 50 blood vessels in the ear was measured.
Measurement of Skin Blood Flow
Abdominal area of mouse skin was shaved and irradiated with UVB. Blood flow was assessed using an Advance Laser (model ALF21R) Doppler flowmeter. The probe was held at six spots of abdominal area, and each reading was the mean of the six measurements.
Statistical Analysis
Data were analyzed using an unpaired two-tailed t-test or one-way ANOVA followed by Dunnett multiple comparisons. P-value of <0.05 was considered to be significant.
Results
It is known that a single exposure of UVB to mice causes marked skin inflammation, most remarkably on the ears. The extent of inflammation was evaluated by measuring the ear swelling responses. When control C57BL/6 mice were exposed to at 5 kJ/m2 to UVB, the ear swelling became detectable within 24 h after irradiation, and the response progressed over the next 24 h as reported previously.15 Mice receiving topical application of 1% indomethacin in acetone immediately after UV exposure showed significantly reduced ear swelling responses at each time point tested, as compared to the control mice that received acetone alone (Figure 1). As indomethacin inhibits COX, an enzyme to produce PGs, it is assumed that PGs play a pivotal role in the induction of UV-induced skin inflammation. As PGE2 is the major PG produced by keratinocytes, we tested the magnitude of swelling responses in mice lacking each receptor subtype. The responses were significantly reduced in EP2−/− mice, EP4−/− mice and EP4 antagonist-treated C57BL/6 mice compared to the control C57BL/6 or EP4+/+ mice at 48 h, although the response was similar in EP1 and EP3 mice (Figure 1). The baseline ear thickness of C57BL/6 with or without the EP4 antagonist, and EP-deficient mice, all without UV radiation, was comparable between these groups (data not shown). These results suggested that endogenous PGE2 mediates UV-induced skin inflammation through EP2 and EP4 receptors. As EP4−/− mice were F2 progeny and individual mice possessed mixed genetic backgrounds, we examined the response of mice administered with the selective EP4 antagonist for further evaluation of EP4 serving as critical receptors.
We then examined the histology, which showed that the ear of C57BL/6 mice treated with or without the EP4 antagonist, and EP2−/− mice, all without UV exposure, were similar (Figure 1). And the histology of the ears of wild-type mice 48 h after UVB irradiation showed significant dermal edema, inflammatory cells infiltration in the upper dermis, and the marginal thickening of the epidermis. This edematous change in the dermis was milder in EP2−/− mice and C57BL/6 mice treated with the EP4 antagonist (Figure 2). Moreover, the infiltration of inflammatory cells was less intensive in those mice (Figure 2). Whereas neutrophils and lymphocytes in the ears of wild-type mice were increased after UVB irradiation, those numbers in EP2−/− mice or C57BL/6 mice treated the EP4 antagonist were lower than those in C57BL/6 mice after irradiation (Figure 3).
The edema response following UV irradiation is dependent on vascular blood flow and vascular permeability. Especially, vascular blood flow can alter fluid movement between the vascular lumen and the interstitial space by increasing the luminal hydrostatic pressure. It is known that increasing local-microenvironmental blood overflow at the early phase after UV exposure is essential to establish UV-induced skin inflammation.1, 16 We therefore measured the diameter of blood vessels in the skin 48 h after UVB irradiation in histological specimens. While blood vessels in wild-type mice were enlarged after UVB irradiation, those in EP2−/− mice or wild-type mice treated with the EP4 antagonist were significantly smaller (Figure 4). We then assessed the blood flow of the abdominal skin at 0, 12, 24, 36 and 48 h after UVB (5 kJ/m2) irradiation using a laser doppler device, and found that the blood flow peaked around 24 h after UV exposure, and was impaired by the EP2 or EP4 signaling blockade (Figure 5). These data suggested that PGE2-EP2/EP4 signaling is critical in acute skin inflammation by enhancing blood flow in the microenvironment.
The above results suggested that both EP2 and EP4 are essential for the development of acute skin inflammation. However, the suppressed level of inflammation by each signaling blockade tended to be lower than the indomethacin treatment. We therefore explored the effect of simultaneous blockade of EP2 and EP4 signaling by administering EP2−/− mice with the EP4 antagonist. The administration of the EP4 antagonist further decreased the reduced ear swelling level of EP2−/− mice (Figure 6). To rule out the possibility that UV-induced PGE2 expression is affected by EP signaling blockade, which eventually affect the skin inflammation, we measured the PGE2 expression in the skin. PGE2 level in the abdominal skin 48 h after irradiation from wild-type and EP2−/− mice with or without the EP4 antagonist were as follows (wild-type C57BL/6 mice; 90.8±10.5, EP2−/− mice; 80.4±12.8, EP2−/− mice with the EP4 antagonist; 76.3±9.0 ng/g tissue: average ±s.d., n=4 each). As a comparison, the baseline PGE2 expression in the skin without UVB irradiation was 0.9±0.3 ng/g tissue: average ±s.d., n=4 each. These results suggest that a significant amount of PGE2 was induced by UV exposure, and the concentration of PGE2 in the skin was not affected by the EP signaling blockade.
Discussion
In this study, we demonstrated that UVB-induced ear swelling response, skin infiltration of neutrophils and lymphocytes, and local blood flow were reduced in EP2−/−, EP4−/− or wild-type mice treated with the EP4 antagonist. These results suggest that endogenous PGE2 mediates UVB-induced acute skin inflammation through EP2 and EP4 receptors.
The UVB-evoked acute swelling response seems to be derived mainly from vasodilatation and resultant exudates. PGE2 exerts its physiological functions by binding to its specific receptors, EP1-EP4, which are well known to be expressed on blood vessels. Vasodilatation is performed through EP2 and EP4 receptors in association with increased cyclic AMP levels by coupling Gs.17, 18, 19 Moreover, PGI2 receptor, IP and PGD2 receptor, DP, are known to increase cyclic AMP levels via Gs.4 In mice, however, PGD2 was barely detected in the skin after UVB irradiation, and PGI2 was not examined in that study.20 We showed that the ear swelling response in EP2 mice (58+12.6 μm) or C57BL/6 mice treated with the EP4 antagonist (72+14.3 μm) was not as low as mice treated with indomethacin (35+8.6 μm). Therefore, we explored the effect of simultaneous blockade of EP2 and EP4 signaling by administering EP2−/− mice with the EP4 antagonist and found that the administration of the EP4 antagonist further decreased the ear swelling of EP2−/− mice (51+5.6 μm). This extent of reduced ear swelling level was not as same as indomethacin-treated group, but quite similar. It might be interesting to investigate the role of other PGs, such as PGI2, in the development of inflammation. In human, both PGD2 and 6-keto PGF1α, stable metabolites of PGI2, were detected in the skin after UVB irradiation.21 The differences may exist in the usage of PGs for the UV-induced skin response between mice and human. Nonetheless, the importance of PGE2, as documented in this study, is particularly notable. As cAMP is the downstream signaling in both EP2 and EP4, we expected that the differences in cAMP production are involved in the synergistic effect of EP2 deficiency and the EP4 antagonist treatment. However, the cAMP level in these mice were barely detected in the skin, and not elevated by UV exposure (data not shown). Moreover, there was no significant difference in cAPM production between these groups. We presume that cAMP is difficult to be detected in the skin en bloc even though it is induced in the blood vessels after UV exposure. One possibility is that PGE2 is produced consistently after UV exposure and may not elevate cAMP levels robust enough to be detected in vivo. The local cAMP production around the vessels may be elevated, but it is difficult to detect this slight increase.
Keratinocytes are the major target of UV radiation and play a central role in the inflammatory and immune modulatory changes observed after UV exposure, at least partly via the UV-induced release of cytokines (IL-1, IL-6, IL-8, IL-10, GM-CSF, TNF-α)22 and COX products.23 IL-6 induces fever and the acute phase response and stimulates leukocytes infiltration in the skin.24 PGE2 plays a role in vasodilatation and in the erythemal response of the skin after solar exposure.25 It has been reported that nitric oxide is involved in the induction of vascular dilatation after UVB exposure.3, 13, 26 As indomethacin treatment did not completely inhibit the UV-induced ear swelling response, there still remains the possibility that other factors are involved in this process. IL-6 and nitric oxide are the candidate in this process at present. So far, using normal human keratinocytes, Pupe et al27 demonstrated that eicosaepentaenoic acid decreased both PGE2 and IL-6 secretion induced by UV-irradiation.27 However, the relationship between PGE2, IL-6 and nitric oxide in vivo events remains unknown and is an interesting issue to be pursued in the future. In this study, we focused on the acute phase of UV-induced skin inflammation. During the acute process of fluid exudation, the role of histamine release from mast cell is important by increasing the vascular permeability.28 Although PGE2 reportedly suppresses mediator release by some mast cell subtypes in vitro,29 it also enhances mediator release from mouse mast cells.30 The mechanisms and EP receptor subtypes responsible for PGE2-mediated inhibition of mast cell activation in UV-induced skin inflammation are incompletely understood.
At cellular levels, UV radiation triggers cytokine production,22 regulates surface expression of adhesion molecules,31 affects cellular mitosis,32 and induces apoptotic cell death of skin components.33 The UV-induced keratinocyte apoptosis is an important factor for preventing from skin cancer formation. EP2 and EP4 signaling blockade can be prophylactic for the acute sunburn reaction in which vasodilatation, exudation, and inflammation participate. On the other hand, it has been already reported that PGE2-induced skin cancer is mediated by EP1 or EP2 receptor signaling,34, 35 and there still remains the possibility that other PGE2 receptor signaling may be involved in this process. The present study clearly demonstrated the deep relationship between PGE2 and acute UV reactions. The involvement of PGE2 and its receptors in more chronic UV-induced conditions, such as cancer development, is an issue to be elucidated.
References
Terui T, Okuyama R, Tagami H . Molecular events occurring behind ultraviolet-induced skin inflammation. Curr Opin Allergy Clin Immunol 2001;1:461–467.
Rhodes LE, Belgi G, Parslew R, et al. Ultraviolet-B-induced erythema is mediated by nitric oxide and prostaglandin E2 in combination. J Invest Dermatol 2001;117:880–885.
Miller CC, Hale P, Pentland AP . Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation. J Biol Chem 1994;269:3529–3533.
Narumiya S, Sugimoto Y, Ushikubi F . Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193–1226.
Ushikubi F, Segi E, Sugimoto Y, et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 1998;395:281–284.
Segi E, Sugimoto Y, Yamasaki A, et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 1998;246:7–12.
Hizaki H, Segi E, Sugimoto Y, et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc Natl Acad Sci USA 1999;96:10501–10506.
Matsuoka Y, Furuyashiki T, Yamada K, et al. Prostaglandin E receptor EP1 controls impulsive behavior under stress. Proc Natl Acad Sci USA 2005;102:16066–16071.
Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002;109:883–893.
Kabashima K, Sakata D, Nagamachi M, et al. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 2003;9:744–749.
Kabashima K, Miyachi Y . Prostanoids in the cutaneous immune response. J Dermatol Sci 2004;34:177–184.
Kuwamoto K, Miyauchi-Hashimoto H, Tanaka K, et al. Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice. J Invest Dermatol 2000;114:241–246.
Warren JB . Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light. FASEB J 1994;8:247–251.
Kabashima K, Murata T, Tanaka H, et al. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol 2003;4:694–701.
Abeyama K, Eng W, Jester JV, et al. A role for NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest 2000;105:1751–1759.
Terui T, Takahashi K, Funayama M, et al. Occurrence of neutrophils and activated Th1 cells in UVB-induced erythema. Acta Derm Venereol 2001;81:8–13.
Davis RJ, Murdoch CE, Ali M, et al. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol 2004;141:580–585.
Imig JD, Breyer MD, Breyer RM . Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice. Am J Physiol Renal Physiol 2002;283:F415–F422.
Kennedy CR, Zhang Y, Brandon S, et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med 1999;5:217–220.
Ruzicka T, Walter JF, Printz MP . Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin. J Invest Dermatol 1983;81:300–303.
Pentland AP, Mahoney M, Jacobs SC, et al. Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. A mechanism for irradiation erythema. J Clin Invest 1990;86:566–574.
Takashima A, Bergstresser PR . Impact of UVB radiation on the epidermal cytokine network. Photochem Photobiol 1996;63:397–400.
Grewe M, Trefzer U, Ballhorn A, et al. Analysis of the mechanism of ultraviolet (UV) B radiation-induced prostaglandin E2 synthesis by human epidermoid carcinoma cells. J Invest Dermatol 1993;101:528–531.
Urbanski A, Schwarz T, Neuner P, et al. Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol 1990;94:808–811.
Rhodes LE, Durham BH, Fraser WD, et al. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest Dermatol 1995;105:532–535.
Deliconstantinos G, Villiotou V, Stravrides JC . Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production. Br J Pharmacol 1995;114:1257–1265.
Pupe A, Moison R, De Haes P, et al. Eicosapentaenoic acid, a n-3 polyunsaturated fatty acid differentially modulates TNF-alpha, IL-1alpha, IL-6 and PGE2 expression in UVB-irradiated human keratinocytes. J Invest Dermatol 2002;118:692–698.
Tharp MD . The interaction between mast cells and endothelial cells. J Invest Dermatol 1989;93:107S–112S.
Peachell PT, MacGlashan Jr DW, Lichtenstein LM, et al. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988;140:571–579.
Nguyen M, Solle M, Audoly LP, et al. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J Immunol 2002;169:4586–4593.
Krutmann J, Grewe M . Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. J Invest Dermatol 1995;105:67S–70S.
Bielenberg DR, Bucana CD, Sanchez R, et al. Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 1998;111:864–872.
Aragane Y, Kulms D, Metze D, et al. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol 1998;140:171–182.
Thompson EJ, Gupta A, Vielhauer GA, et al. The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1. Neoplasia 2001;3:402–410.
Sung YM, He G, Fischer SM . Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development. Cancer Res 2005;65:9304–9311.
Acknowledgements
We appreciate Dr T Terui for special advice, K Deguchi and T Fujiwara for animal care, and ONO Pharmaceutical for the PGE receptor selective compounds, ONO-AE3-208. The authors have no conflicting financial interests. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Shiseido Research Foundation, and Cosmos Technical Science Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kabashima, K., Nagamachi, M., Honda, T. et al. Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors. Lab Invest 87, 49–55 (2007). https://doi.org/10.1038/labinvest.3700491
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/labinvest.3700491
Keywords
This article is cited by
-
Protection against UVB deleterious skin effects in a mouse model: effect of a topical emulsion containing Cordia verbenacea extract
Photochemical & Photobiological Sciences (2021)
-
Prostaglandin E2 is critical for the development of niacin-deficiency-induced photosensitivity via ROS production
Scientific Reports (2013)
-
Atopic Keratinocytes Induce Increased Neurite Outgrowth in a Coculture Model of Porcine Dorsal Root Ganglia Neurons and Human Skin Cells
Journal of Investigative Dermatology (2012)
-
Polyhydroxylated fatty alcohols derived from avocado suppress inflammatory response and provide non-sunscreen protection against UV-induced damage in skin cells
Archives of Dermatological Research (2011)
-
The role of the EP receptors for prostaglandin E2 in skin and skin cancer
Cancer and Metastasis Reviews (2011)